25/02/2019 16:29:47

CLASS ACTION UPDATE for DBVT, ALKS, GSM and MU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

DBV Technologies S.A. (NASDAQ: DBVT)

Class Period: February 14, 2018 - December 19, 2018

Lead Plaintiff Deadline: March 18, 2019

Join the action: https://www.zlk.com/pslra-1/dbv-technologies-s-a-loss-form?wire=3

About the lawsuit: During the class period, DBV Technologies S.A. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) DBV Technologies' Biologics License Application ("BLA") for Viaskin Peanut failed to provide the FDA with sufficient data on manufacturing procedures and quality controls; (2) consequently, DBV Technologies voluntarily withdrew the BLA for Viaskin Peanut; and (3) as a result, defendants' statements about DBV Technologies' business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

To learn more about the DBV Technologies S.A. class action contact jlevi@levikorsinsky.com.

Alkermes plc (NASDAQGS: ALKS)

Class Period: February 17, 2017 - November 1, 2018

Lead Plaintiff Deadline: February 25, 2019

Join the action: https://www.zlk.com/pslra-1/alkermes-plc-loss-form?wire=3

About the lawsuit: Alkermes plc allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (1) the FDA had advised Alkermes to follow a certain protocol in connection with its New Drug Application submission for its drug ALKS 5461; (2) Alkermes had failed to follow that protocol; (3) consequently, an FDA advisory committee voted 21 to 2 against the approval of ALKS 5461; and (4) as a result, Alkermes’ public statements were materially false and/or misleading at all relevant times.

To learn more about the Alkermes plc class action contact jlevi@levikorsinsky.com.

Ferroglobe PLC (NASDAQ: GSM)

Class Period: August 21, 2018 - November 26, 2018

Lead Plaintiff Deadline: March 25, 2019

Join the action: https://www.zlk.com/pslra-1/ferroglobe-plc-loss-form?wire=3

About the lawsuit: Ferroglobe PLC allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) there was excess supply of the Company’s products; (2) demand for the Company’s products was declining; (3) as a result, the pricing of the Company’s products would be materially impacted; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

To learn more about the Ferroglobe PLC class action contact jlevi@levikorsinsky.com.

Micron Technology Inc. (NASDAQGS: MU)

Class Period: September 26, 2017 - November 19, 2018

Lead Plaintiff Deadline: March 25, 2019

Join the action: https://www.zlk.com/pslra-1/micron-technology-inc-loss-form?wire=3

About the lawsuit: Micron Technology Inc. allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (1) the Company engaged in anti-competitive behavior, including artificially restricting supply growth of DRAM; (2) these anti-competitive efforts were reasonably likely to lead to regulatory scrutiny; (3) the Company’s anti-competitive efforts artificially boosted its operating metrics; (4) as a result, the Company’s financial performance, including revenue, was overstated; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more about the Micron Technology Inc. class action contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Toll Free: (877) 363-5972

Fax: (212) 363-7171

www.zlk.com 

250x148_zlk.jpg

Related content
19 Jul - 
Micron Technology Announces Expiration of Shareholder ..
10 Jul - 
Micron Announces Pricing of $1.75 Billion of Senior Not..
10 Jul - 
Micron Announces Offering of Senior Notes
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
EDF signs two bilateral sustainable revolving credit facilities with Crédit Agricole CIB and Societe Generale CIB, bringing the total of its sustainability-linked loans to over €5 billion
2
Maroc Telecom_H1 2019 Consolidated Results
3
Sienna Resources Scheduled to Commence Drilling on Flagship Slättberg Nickel-Copper-Cobalt Project in Sweden in August
4
Paysafe announces YouTube partnership
5
McPhy Energy: Equity financing line

Related stock quotes


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 July 2019 20:12:53
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190703.1 - EUROWEB1 - 2019-07-22 21:12:53 - 2019-07-22 20:12:53 - 1000 - Website: OKAY